Bionano Genomics, Inc. — Director's Dealing 2018

Aug 27, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2018-08-23

Reporting Person: Rosy Shine Ltd (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1134000	Direct

Footnotes

F1: Represents the conversion of an outstanding convertible promissory note in the principal amount of $5,000,000, plus $209,315.07 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $6.125 per share.